Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Seebio Biotech is a China-based life science and biopharmaceutical raw materials company focused on IVD reagents, biochemical reagents, biopharma inputs, and health-related specialty ingredients. The company started as a domestic manufacturer of IVD raw materials and has expanded into a broader integrated model spanning R&D, production, warehousing, and international distribution. Its offerings include diagnostic raw materials across biochemical, immunological, molecular, blood, microbial, and POCT applications, as well as vitamins, proteins, natural extracts, pharmaceutical excipients, and related consumables. Seebio also describes in-house technology platforms in protein expression and purification, polyethylene glycol chemistry, synthetic biology, and derivative technologies. The business appears to be primarily a commercial supplier and technology application platform rather than a therapeutic drug developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Seebio Biotech.